These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4685907)
1. Role of the sympathetic nervous system in supporting cardiac function in essential arterial hypertension. Guazzi M; Magrini F; Fiorentini C; Polese A Br Heart J; 1973 Jan; 35(1):55-64. PubMed ID: 4685907 [No Abstract] [Full Text] [Related]
2. Importance of the adrenergic nervous system in the support of cardiac function in patients with primary arterial hypertension. Guazzi M; Polese A; Fiorentini C; Magrini F Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():151s-4. PubMed ID: 4536607 [No Abstract] [Full Text] [Related]
3. Effect of methyldopa, reserpine and guanethidine on hindleg vascular resistance. Mohammed S; Gaffney TE; Yard AC; Gomez H J Pharmacol Exp Ther; 1968 Apr; 160(2):300-7. PubMed ID: 5651373 [No Abstract] [Full Text] [Related]
4. [Therapy of essential arterial hypertension. IV. Drugs with peripheral sympathetic action]. Fossati C Clin Ter; 1980 May; 93(4):457-79. PubMed ID: 6106537 [No Abstract] [Full Text] [Related]
5. Correlation of pathophysiology and pharmacotherapy in primary hypertension. Koch-Weser J Am J Cardiol; 1973 Sep; 32(4):499-510. PubMed ID: 4593182 [No Abstract] [Full Text] [Related]
6. Effects of sympathetic and central nervous system alterations on the blood pressure responses to phentolamine. Hilliard CC; Bagwell EE; Daniell HB J Pharmacol Exp Ther; 1972 Mar; 180(3):743-7. PubMed ID: 4401160 [No Abstract] [Full Text] [Related]
7. [Comparative evaluation of the therapeutic effect and mechanism of action of isobarin and aldomet in hypertension]. Erina EV; Zamyslova KN; Il'ina LI; Glezer GA; Pershakova LP; Vyshnepol'skiĭ IuIa; Labeeva TN Kardiologiia; 1967 Mar; 7(3):35-41. PubMed ID: 4883577 [No Abstract] [Full Text] [Related]
8. [The effect of guanethidine and reserpine in angiotensin sensitivity in man]. Kállay K; Káldor A; Gachályi B; Sebestyén K; Földvári A Orv Hetil; 1974 Dec; 115(49):2917-9. PubMed ID: 4376593 [No Abstract] [Full Text] [Related]
9. [The sympathetic nervous system and essential hypertension]. Distler A Med Klin; 1979 Nov; 74(47):1735-41. PubMed ID: 392290 [No Abstract] [Full Text] [Related]
10. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution. Kisin I; Yuzhakov S Eur J Pharmacol; 1976 Feb; 35(2):253-60. PubMed ID: 1248504 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of exercise hypotension after sympathetic blockade. Khatri IM; Cohn JN Am J Cardiol; 1970 Mar; 25(3):329-38. PubMed ID: 5443912 [No Abstract] [Full Text] [Related]
14. The clinician's guide to pharmacology of antihypertensive agents. Gottlieb TB; Chidsey CA Geriatrics; 1976 Jan; 31(1):99-110. PubMed ID: 1107149 [No Abstract] [Full Text] [Related]
15. Pathophsiological significance of sympathetic activity in cardiovascular diseases. Kimura K Jpn Circ J; 1974 Mar; 38(3):181-94. PubMed ID: 4152034 [No Abstract] [Full Text] [Related]
16. Human serum dopamine- -hydroxylase. Relationship to hypertension and sympathetic activity. Horwitz D; Alexander RW; Lovenberg W; Keiser HR Circ Res; 1973 May; 32(5):594-9. PubMed ID: 4713201 [No Abstract] [Full Text] [Related]
17. Persistence of reflex sympathetic nervous system activity in man on guanethidine or reserpine. Coffman JD Circulation; 1967 Feb; 35(2):339-46. PubMed ID: 6022802 [No Abstract] [Full Text] [Related]